Antipsychotic Polypharmacy Versus Monotherapy in Elderly Patients with Chronic Schizophrenia: A Clinical Trial

References

• Viola R, Csukonyi K, Doró P, Janka Z, Soós G. Reasons for polypharmacy among psychiatric patients. Pharma World Sci 2004; 26(3): 143–7. [CrossRef]
   Google Scholar
• Brend R, Herman E, Marc Z. Patterns of drug prescription in a psychiatric outpatient care unit, the issue of polypharmacy. German J Psychiatry 2008; 11: 1–6.
   Google Scholar
• Xiang YT, Dickerson F, Kreyenbuhl J, Ungvari GS, Wang CY, Si TM, et al. Common use of antipsychotic polypharmacy in older Asian patients with schizophrenia (2001–2009). J Clin Psychopharmacol 2012; 32(6): 809–13. [CrossRef]
   Web of Science ®Google Scholar
• Linden M, Scheel T, Xaver EF. Dosage finding and outcome in the treatment of schizophrenic inpatients with amisulpride. Results of a drug utilization observation study. Hum Psychopharmacol 2004; 19(2): 111–9. [CrossRef]
   Google Scholar
• Kennedy NB, Procyshyn RM. Rational antipsychotic polypharmacy. Can J Clin Pharmacol 2000; 7(3): 155–9.
   Google Scholar
• Flaum M, Karp S, Parks J. Technical report of psychiatric polypharmacy. A series of technical reports prepared by the: National Association of State Mental Health Program Directors (NASMHPD) 2001; 1–24.
   Google Scholar
• Ghaemi N. Polypharmacy in Psychiatry. New York: Marcel Dekker, 1st, 2002.
   Google Scholar
• Kingsbury SJ, Yi D, Simpson GM. Psychopharmacology: rational and irrational polypharmacy. Psychiatr Serv 2001; 52(8): 1033–6. [CrossRef]
   Web of Science ®Google Scholar
• Ryan A, Jacques I. Medication compliance in older people. Elderly Care 1997; 5: 16–20.
   Google Scholar
• Statistical Center of Iran. Management & Planning Organization, Status of the Aged Nation Wide, Islamic Republic of Iran: 2002.
   Google Scholar
• Mehl B, Santell J. Projecting future drug expenditures. Am J Health Syst Pharm 1999; 56(1): 31–9.
   Web of Science ®Google Scholar
• Wyles H, Rehman HU. Inappropriate polypharmacy in the elderly. Eur J Intern Med 2005; 16(5): 311–3. [CrossRef]
   Google Scholar
• Woodard K, Franklin R. Treating elderly patients. Pharmacist 1999; 24: HS7–16.
   Google Scholar
• Dawling S, Crome P. Clinical pharmacokinetic considerations in the elderly. An update. Clin Pharmacokinetic 1989; 17(4): 236–63. [CrossRef]
   Web of Science ®Google Scholar
• Hallas J, Worm J, Beck-Nielsen J, Gram LF, Grodum E, Damsbo N, et al. Drug related events and drug utilization in patients admitted to a geriatric hospital department. Dan Med Bull 1991; 38(5): 417–20.
   Google Scholar
• Lamy PP. Prescribing for the Elderly. Littleton: Mess PSG Public Company; 1980.
   Google Scholar
• Sadock BJ, Sadock VA. Kaplan and Sadock's Synopsis of Psychiatry. 10th ed. Philladelphia: Lippincott Williams and Wilkins: 2007.
   Google Scholar
• Steven J, Megan L. Psychiatric Polypharmacy: the good, the bad, and the ugly. Psychiatric Times 2007; 4: 32.
   Google Scholar
• Sadock BJ, Sadock VA. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 9th ed. Philadelphia: Lippincott Williams and Wilkins, 2009.
   Google Scholar
• Rittmannsberger H, Meise U, Schauflinger K, Horvath E, Donat H, Hinterhuber H. Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics. Eur Psychiatry 1999; 14(1): 33–40. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Weinmann S, Janssen B, Gaebel W. Switching antipsychotics in inpatient schizophrenia care: predictors and outcomes. J Clin Psychiatry 2004; 65(8): 1099–105. [CrossRef]
   Web of Science ®Google Scholar
• Tapp A, Wood A, Secret L, Erdmann J, Cubberley L, Kilzieh N. Combination antipsychotic therapy in clinical practice. Psychiatr Serv 2003; 54(1): 55–9. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Ito C, Kubota Y, Sato M. A prospective survey on drug choice for prescriptions for admitted patients with schizophrenia. Psychiatry and Clinical Neurosciences 1999; 53(Suppl): S35–40.
   Google Scholar
• Najim H, Heath D, Singh P. Antipsychotic prescribing before clozapine in a community psychiatric hospital: a case note review. Psychiatr Danub 2013; 25(Suppl 2): S165–70.
   Google Scholar
• Miller AL, Chiles JA, Chiles JK, Crismon ML, Rush AJ, Shon SP. The Texas medication algorithm project (TMAP) schizophrenia algorithms. Journal of Clinical Psychiatry 1999; 60(10): 649–57. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Clark RE, Bartels SJ, Mellman TA, Peacock WJ. Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy. Schizophr Bull 2002; 28(1): 75–84. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Procyshyn RM, Kennedy NB, Tse G, Thompson B. Antipsychotic polypharmacy: a survey of discharge prescriptions from a tertiary care psychiatric institution. Canadian Journal of Psychiatry 2001; 46(4): 334–9.
   Web of Science ®Google Scholar
• Williams CL, Johnstone BM, Kesterson JG, Javor KA, Schmetzer AD. Evaluation of antipsychotic and. concomitant medication use patterns in patients with schizophrenia. Med Care 1999; 37(4 Suppl Lilly): AS81–6.
   Web of Science ®Google Scholar
• Sim K, Su A, Fujii S, Yang SY, Chong MY, Ungvari GS et al. Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia. Br J Clin Pharmacol 2004; 58(2): 178–83. [CrossRef]
   PubMed Web of Science ®Google Scholar
• Abdolahian E, Mohared F, Fyyazi MR. Haloperidol versus risperidone: a comparison of beneficial effect on cognitive function of patients with chronic schizophrenia. Iranian Journal of Psychiatry and Behavoral Sciences 2008; 2(1): 14–20.
   Google Scholar
• Robiee M, Khorramdel K, et al. Factor structure, validity and reliability of the modified Yale-Brown obsessive compulsive scale for body dysmorphic disorder in students. Iranian Journal of Psychiatry and Clinical Psychology 2010; 15(4): 342–50.
   Google Scholar
• Mokhtarzadeh A, Ghoreshzadeh MA, et al. Reliability and validity of Abridged versus of the Farsi version of scale to assess unawareness of mental disorders(SUMO) in psychotic mania. Iranian Journal of Psychiatry and Clinical Psychology 2010; 16(31): 181–6.
   Google Scholar
• Akhondzadeh SH. Pharmacotherapy of schizophrenia. Iranian Journal of Psychiatry 2006; 1(2): 46–53.
   Google Scholar